Jackmup-logo

 

                                                                                                                                   

Email:info@jackmup.com

Tel:+91 7219394600

googleplus facebook twitter linkedin

_A_


  549-18-8
  Amitriptyline hcl
  Innovators:
Merck & Co.
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)
  Available dmf:
CEPJapan DMFKorea DMFUS DMFOther
 

 59277-89-3
 Acyclovir
  Innovators:
GlaxoSmithKline
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)N - OPHTHALMIC
  Available dmf:
Canada DMFCEPKorea DMFUS DMF
 

 850140-73-7
 Afatinib dimaleate
  Innovators:
Boehringer Ingelheim
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 66734-13-2
 Alclometasone dipropionate
  Innovators:
Schering-Plough
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
Japan DMFUS DMF
 

 260055-05-8
 Alendronate sodium
  Innovators:
Merck & Co.
  Therapeutic category:
M-MUSCULO-SKELETAL SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
Canada DMFEU DMFJapan DMFUS DMF
 

  315-30-0
 Allopurinol
  Innovators:
GlaxoSmithKline
  Therapeutic category:
M-MUSCULO-SKELETAL SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
Canada DMFCEPJapan DMFUS DMFOther
 

  51022-69-6
 Amcinonide
  Innovators:
Astellas
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
Canada DMFEU DMFJapan DMFUS DMF
 

 154229-18-2
 Abiraterone Acetate
  Innovators:
McNeil
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
EU DMFUS DMF
 

 90779-69-4
 Atosiban Acetate
  Innovators:
Ferring
  Therapeutic category:
G-GENITO-URINARY SYSTEM & SEX HORMONAL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
EU DMF
 

 64228-81-5
 Atracurium besylate
  Innovators:
GlaxoSmithKline
  Therapeutic category:
M-MUSCULO-SKELETAL SYSTEM
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
Canada DMFCEPEU DMFUS DMFOther
 

  320-67-2
 Azacitidine
  Innovators:
Pfizer
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
EU DMFUS DMF
 

 83905-01-5
 Azithromycin dihydrate
  Innovators:
Pfizer
  Therapeutic category:
J-GENERAL ANTI-INFECTIVES SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)F - PARENTERAL ORDINARY (Injectables)N - OPHTHALMIC
  Available dmf:
Brazil DMFCanada DMFCEPUS DMFOther
 

 78110-38-0
 Aztreonam
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
J-GENERAL ANTI-INFECTIVES SYSTEM
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMF
 

  120511-73-1
 Anastrozole
  Innovators:
Astra Zeneca
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
Canada DMFCEPJapan DMFUS DMFOther
 

 166663-25-8
 Anidulafungin
  Innovators:
Eli Lilly
  Therapeutic category:
J-GENERAL ANTI-INFECTIVES SYSTEM
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
-
 

 503612-47-3
 Apixaban
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
B-BLOOD AND BLOOD FORMING ORGANS
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMF
 

 608141-41-9
 Apremilast
  Innovators:
Celgenex
  Therapeutic category:
A - ORAL SOLID ORDINARY
  Formulation:
M-MUSCULO-SKELETAL SYSTEM
  Available dmf:
-
 

 129722-12-9
 Aripiprazole
  Innovators:
Otsuka
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…) G - PARENTERAL LONG-ACTING (Injectables)
  Available dmf:
EU DMFJapan DMFKorea DMFUS DMFOther
 

  29122-68-7
 Atenolol
  Innovators:
Astra Zeneca
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
CEPUS DMFJapan DMF
 

 82248-59-7
 Atomoxetine hcl
  Innovators:
Eli Lilly
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)
  Available dmf:
Canada DMFEU DMFKorea DMFUS DMF
 

 134523-03-08
 Atorvastatin calcium
  Innovators:
Pfizer
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
Brazil DMFCanada DMFCEPEU DMFKorea DMFUS DMFOther
 

 90779-69-4
 Atosiban Acetate
  Innovators:
Ferring
  Therapeutic category:
G-GENITO-URINARY SYSTEM & SEX HORMONAL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
EU DMF
 

 64228-81-5
 Atracurium besylate
  Innovators:
GlaxoSmithKline
  Therapeutic category:
M-MUSCULO-SKELETAL SYSTEM
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
Canada DMFCEPEU DMFUS DMFOther
 

 

_B_


 5534-09-8
 Beclomethasone dipropionate
  Innovators:
GlaxoSmithKline
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)P - OTICQ - NASAL TOPICALR - LUNG ADMINISTRATION (Inhalation)
  Available dmf:
CEPJapan DMFUS DMFEU DMFOther
 

 987-24-6
 Betamethasone acetate
  Innovators:
Schering-Plough
  Therapeutic category:
H-SYSTEMIC HORMONAL PREPAR
  Formulation:
G - PARENTERAL LONG-ACTING (Injectables)M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
US DMFJapan DMFEU DMFCanada DMF
 

 378-44-9
 Betamethasone base
  Innovators:
Schering-Plough
  Therapeutic category:
H-SYSTEMIC HORMONAL PREPAR
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)N - OPHTHALMIC
  Available dmf:
Japan DMFCEP
 

 5593-20-4
 Betamethasone dipropionate
  Innovators:
Schering-Plough
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
F - PARENTERAL ORDINARY (Injectables)G - PARENTERAL LONG-ACTING (Injectables)M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
US DMFCEPCanada DMFOther
 

 2152-44-5
 Betamethasone valerate
  Innovators:
Schering-Plough
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
US DMFJapan DMFCEPEU DMFCanada DMFOther
 

  90357-06-5
 Bicalutamide
  Innovators:
Astra Zeneca
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFJapan DMFEU DMFCanada DMFCEPOther
 

 155206-00-1
 Bimatoprost
  Innovators:
Allergan
  Therapeutic category:
S-SENSORY ORGANS
  Formulation:
N - OPHTHALMIC
  Available dmf:
US DMFEU DMFCanada DMF
 

 9041-93-4
 Bleomycin sulfate
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFEU DMFCanada DMFOther
 

 390800-88-1
 Bortezomib
  Innovators:
Millennium Pharma
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFEU DMFCanada DMFKorea DMFBrazil DMFJapan DMFOther
 

 913611-97-9
 Brexpiprazole
  Innovators:
Otsuka
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 22260-51-1
 Bromocriptine mesylate
  Innovators:
Novartis
  Therapeutic category:
G-GENITO-URINARY SYSTEM & SEX HORMONAL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFJapan DMFCEPCanada DMFBrazil DMFOther
 

 51333-22-3
 Budesonide
  Innovators:
Astra Zeneca
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTINGH - RECTAL SYSTEMIC (Suppositories)Q - NASAL TOPICALR - LUNG ADMINISTRATION (Inhalation)
  Available dmf:
US DMFJapan DMFEU DMFCEPOther
 

  52485-79-7
 Buprenorphine base
  Innovators:
Lohmann Therapy Systems
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFCEP
 

 53152-21-9
 Buprenorphine hcl
  Innovators:
Indivior Inc.
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFCanada DMFCEP
 

 58786-99-5
 Butorphanol tartrate
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
F - PARENTERAL ORDINARY (Injectables)I - NASAL SYSTEMIC
  Available dmf:
US DMFEU DMFCanada DMFOther
 

  2152-44-5
 Betamethasone valerate
  Innovators:
Schering-Plough
  Therapeutic category:
D-DERMATOLOGICALS )
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…
  Available dmf:
US DMFJapan DMFCEPEU DMFCanada DMFOther
 

 

_C_


 15663-27-1
 Cisplatin
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
CEPEU DMF
 

 81103-11-9
 Clarithromycin
  Innovators:
AbbVie Inc
  Therapeutic category:
J-GENERAL ANTI-INFECTIVES SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTINGD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFEU DMFCanada DMFCEPKorea DMF
 

 25122-46-7
 Clobetasol propionate
  Innovators:
Lab. Galderma
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
US DMFJapan DMFCEPCanada DMFKorea DMFEU DMFOther
 

 1402820-62-5
 Cabazitaxel
  Innovators:
Sanofi Aventis
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFEU DMFOther
 

  81409-90-7
 Cabergoline
  Innovators:
Pfizer
  Therapeutic category:
G-GENITO-URINARY SYSTEM & SEX HORMONAL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFJapan DMFEU DMFCEPKorea DMFBrazil DMFOther
 

  112965-21-6
 Calcipotriene (calcipotriol)
  Innovators:
LEO Pharma
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
US DMFCEPEU DMFCanada DMFOther
 

 32222-06-3
 Calcitriol
  Innovators:
Abbvie
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARYF - PARENTERAL ORDINARY (Injectables)M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
US DMFCEPEU DMF
 

 154361-50-9
 Capecitabine
  Innovators:
Roche
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
CEPUS DMFEU DMFCanada DMFOther
 

 38821-49-7
 Carbidopa
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFJapan DMFCEPEU DMFCanada DMFOther
 

 41575-94-4
 Carboplatin
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFCEPEU DMF
 

 868540-17-4
 Carfilzomib
  Innovators:
Amgen
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
-
 

 72956-09-3
 Carvedilol base
  Innovators:
Roche
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFEU DMFCEPKorea DMFOther
 

 610309-89-2
 Carvedilol phosphate
  Innovators:
Roche
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
G - PARENTERAL LONG-ACTING (Injectables)
  Available dmf:
US DMFOther
 

 162808-62-0
 Caspofungin acetate
  Innovators:
Merck & Co.
  Therapeutic category:
J-GENERAL ANTI-INFECTIVES SYSTEM
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFEU DMFCanada DMFBrazil DMFOther
 

  302-22-7
 Chlormadinone acetate
  Innovators:
Pfizer
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
Japan DMFEU DMF
 

 59865-13-3
 Ciclosporin
  Innovators:
Novartis
  Therapeutic category:
S-SENSORY ORGANS
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)F - PARENTERAL ORDINARY (Injectables)N - OPHTHALMIC
  Available dmf:
Japan DMFUS DMFCanada DMFCEPKorea DMFEU DMFOther
 

 73963-72-1
 Cilostazol
  Innovators:
Otsuka
  Therapeutic category:
B-BLOOD AND BLOOD FORMING ORGANS
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFJapan DMFKorea DMFEU DMFOther
 

 364782-34-3
 Cinacalcet hcl
  Innovators:
Amgen
  Therapeutic category:
H-SYSTEMIC HORMONAL PREPAR
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFEU DMF
 

 96946-42-8
 Cisatracurium besylate
  Innovators:
GlaxoSmithKline
  Therapeutic category:
M-MUSCULO-SKELETAL SYSTEM
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFEU DMFCanada DMF
 

  120202-66-6
 Clopidogrel bisulfate
  Innovators:
Sanofi Aventis
  Therapeutic category:
B-BLOOD AND BLOOD FORMING ORGANS
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
CEPCanada DMFEU DMFUS DMFKorea DMFOther
 

 1004316-88-4
 Cobicistat
  Innovators:
Gilead Sciences
  Therapeutic category:
J-GENERAL ANTI-INFECTIVES SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 427-51-0
 Cyproterone acetate
  Innovators:
Bayer
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFCEP
 

 

_D_


 872728-81-9
 Dabigatran etexilate
  Innovators:
Boehringer Ingelheim
  Therapeutic category:
B-BLOOD AND BLOOD FORMING ORGANS
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFEU DMFCanada DMFKorea DMF
 

 133099-07-7
 Darifenacin hbr
  Innovators:
Novartis
  Therapeutic category:
G-GENITO-URINARY SYSTEM & SEX HORMONAL
  Formulation:
B - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFEU DMF
 

 302962-49-8
 Dasatinib anhydrous
  Innovators:
Bristol-Myers Squibb
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
EU DMF
 

 863127-77-9
 Dasatinib monohydrate
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMF
 

 23541-50-6
 Daunorubicin hcl
  Innovators:
Sanofi Aventis
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFCEPCanada DMFOther
 

 201530-41-8
 Deferasirox
  Innovators:
Novartis
  Therapeutic category:
V-VARIOUS
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFEU DMFBrazil DMFOther
 

  138-14-7
 Deferoxamine mesylate
  Innovators:
Novartis
  Therapeutic category:
V-VARIOUS
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
CEPUS DMFEU DMFBrazil DMFOther
 

 20423-99-8
 Deprodone propionate
  Innovators:
Abbott
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
Japan DMF
 

  100643-71-8
 Desloratadine
  Innovators:
Schering-Plough
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTINGD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)
  Available dmf:
US DMFEU DMFOther
 

 62357-86-2
 Desmopressin acetate
  Innovators:
Sanofi Aventis
  Therapeutic category:
H-SYSTEMIC HORMONAL PREPAR
  Formulation:
A - ORAL SOLID ORDINARYF - PARENTERAL ORDINARY (Injectables)I - NASAL SYSTEMIC
  Available dmf:
US DMFCEPEU DMFOther
 

 638-94-8
 Desonide
  Innovators:
Lab. Galderma
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
US DMFEU DMFCanada DMFOther
 

 808-48-0
 Desoxycorticosterone (Desoxycortone) Pivalate
  Innovators:
Schering-Plough
  Therapeutic category:
H-SYSTEMIC HORMONAL PREPAR
  Formulation:
G - PARENTERAL LONG-ACTING (Injectables)
  Available dmf:
EU DMF
 

 93413-62-8
 Desvenlafaxine base
  Innovators:
Pfizer
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
B - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFEU DMFOther
 

  93414-01-1
 Desvenlafaxine fumarate
  Innovators:
Pfizer
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
B - ORAL SOLID LONG-ACTING
  Available dmf:
US DMF
 

  386750-22-7
 Desvenlafaxine succinate
  Innovators:
Pfizer
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
B - ORAL SOLID LONG-ACTING 2
  Available dmf:
US DMFCanada DMFOther
 

  33755-46-3
 Dexamethasone -17 valerate
  Innovators:
D-DERMATOLOGICALS
  Therapeutic category:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Formulation:
Japan DMF
  Available dmf:
-
 

 364-98-7
 Diazoxide
  Innovators:
Schering-Plough
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFEU DMFJapan DMF
 

  33564-31-7
 Diflorasone diacetate
  Innovators:
Pfizer
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
US DMFJapan DMFEU DMFCanada DMF
 

 23674-86-4
 Difluprednate
  Innovators:
Mitsubishi Chemical
  Therapeutic category:
S-SENSORY ORGANS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)N - OPHTHALMIC
  Available dmf:
US DMFJapan DMFEU DMFCanada DMFOther
 

 6190-39-2
 Dihydroergotamine mesylate
  Innovators:
Novartis
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYF - PARENTERAL ORDINARY (Injectables)I - NASAL SYSTEMIC
  Available dmf:
US DMFCEPOther
 

 8067-24-1
 Dihydroergotoxine mesylate
  Innovators:
Novartis
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFJapan DMFCEPOther
 

 33286-22-5
 Diltiazem hcl
  Innovators:
Mitsubishi Tanabe Pharma
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTINGF - PARENTERAL ORDINARY (Injectables)
  Available dmf:
Canada DMFUS DMFCEP
 

  624-49-7
 Dimethyl fumarate
  Innovators:
Biogen Idec
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
EU DMFUS DMF
 

  165800-07-7
 Disodium Zoledronate
  Innovators:
Axsome Therapeutics
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
-
  Available dmf:
-
 

 114977-28-5
 Docetaxel
  Innovators:
Sanofi Aventis
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
EU DMFUS DMFCanada DMFKorea DMFJapan DMFOther
 

 120014-06-1
 Donepezil hcl
  Innovators:
Eisai
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
Canada DMFEU DMFUS DMFJapan DMFOther
 

 130693-82-2
 Dorzolamide hcl
  Innovators:
Merck & Co.
  Therapeutic category:
S-SENSORY ORGANS
  Formulation:
N - OPHTHALMIC
  Available dmf:
US DMFCanada DMFCEP
 

  1229-29-4
 Doxepin hcl
  Innovators:
Pfizer
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFCEPEU DMF
 

 54573-75-0
 Doxercalciferol
  Innovators:
Genzyme
  Therapeutic category:
H-SYSTEMIC HORMONAL PREPAR
  Formulation:
A - ORAL SOLID ORDINARYF - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMF
 

 25316-40-9
 Doxorubicin hcl
  Innovators:
Johnson & Johnson
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)G - PARENTERAL LONG-ACTING (Injectables)
  Available dmf:
US DMFJapan DMFCEPCanada DMFOther
 

 67392-87-4
 Drospirenone
  Innovators:
Bayer
  Therapeutic category:
G-GENITO-URINARY SYSTEM & SEX HORMONAL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFEU DMFCanada DMFCEPKorea DMFOther
 

 136434-34-9
 Duloxetine hcl
  Innovators:
Eli Lilly
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
CEPEU DMFUS DMFCanada DMFKorea DMF
 

 

_E_


 480449-70-5
 Edoxaban
  Innovators:
Daiichi
  Therapeutic category:
B-BLOOD AND BLOOD FORMING ORGANS
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 104121-92-8
 Eldecalcitol
  Innovators:
Chugai Pharma
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 177834-92-3
 Eletriptan hbr
  Innovators:
Pfizer
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFEU DMFCanada DMFOther
 

 496775-61-2
 Eltrombopag olamine
  Innovators:
GlaxoSmithKline
  Therapeutic category:
B-BLOOD AND BLOOD FORMING ORGANS
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 864821-90-9
 Eluxadoline
  Innovators:
Allergan
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 864070-44-0
 Empagliflozin
  Innovators:
Boehringer Ingelheim
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 56390-09-1
 Epirubicin hcl
  Innovators:
Pfizer
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
Canada DMFCEPEU DMFJapan DMFUS DMFKorea DMFOther
 

 188627-80-7
 Eptifibatide
  Innovators:
Millennium Pharma
  Therapeutic category:
B-BLOOD AND BLOOD FORMING ORGANS
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFEU DMFCanada DMF
 

 129-51-1
 Ergometrine (ergonovine) maleate
  Innovators:
Novartis
  Therapeutic category:
G-GENITO-URINARY SYSTEM & SEX HORMONAL
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFJapan DMFCanada DMFCEPOther
 

 379-79-3
 Ergotamine tartrate
  Innovators:
Novartis
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFJapan DMFCEPOther
 

 183319-69-9
 Erlotinib hcl
  Innovators:
Roche
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFEU DMFCanada DMFKorea DMF
 

 138729-47-2
 Eszopiclone
  Innovators:
Sanofi Aventis
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFCanada DMFJapan DMF
 

 41340-25-4
 Etodolac
  Innovators:
Pfizer
  Therapeutic category:
M-MUSCULO-SKELETAL SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
CEPJapan DMFUS DMFEU DMFOther
 

  33419-42-0
 Etoposide
  Innovators:
Bristol-Myers Squibb
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARYF - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFJapan DMFCEPOther
 

 141732-74-9
 Exenatide
  Innovators:
Amylin Pharma
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)G - PARENTERAL LONG-ACTING (Injectables)
  Available dmf:
US DMFEU DMFKorea DMFOther
 

 163222-33-1
 Ezetimibe
  Innovators:
Merck & Co.
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
EU DMFUS DMFCanada DMFBrazil DMFOther
 

 

_F_


  104227-87-4
 Famciclovir
  Innovators:
Novartis
  Therapeutic category:
J-GENERAL ANTI-INFECTIVES SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
Canada DMFEU DMFUS DMFKorea DMF
 

 144060-53-7
 Febuxostat
  Innovators:
Teijin Pharma
  Therapeutic category:
M-MUSCULO-SKELETAL SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
Canada DMFUS DMFEU DMFOther
 

 162359-55-9
 Fingolimod
  Innovators:
Mitsubishi Tanabe Pharma
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY US
  Available dmf:
DMFCanada DMFOther
 

 75607-67-9
 Fludarabine phosphate
  Innovators:
Southern Research Institute
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARYF - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFCEPCanada DMFOther
 

 514-36-3
 Fludrocortisone acetate
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
H-SYSTEMIC HORMONAL PREPAR
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFEU DMF
 

 3385-03-3
 Flunisolide
  Innovators:
Hoffmann-La Roche
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
Q - NASAL TOPICALR - LUNG ADMINISTRATION (Inhalation)
  Available dmf:
Canada DMFEU DMFUS DMFOther
 

  67-73-2
 Fluocinolone acetonide
  Innovators:
Valeant
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)N - OPHTHALMICP - OTICT - VAGINAL/INTRA-UTERINE (Women Health)
  Available dmf:
US DMFJapan DMFEU DMFOther
 

 356-12-7
 Fluocinonide
  Innovators:
Medicis Pharma
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
US DMFJapan DMFEU DMFCanada DMFOther
 

 3801-06-7
 Fluorometholone acetate
  Innovators:
Alcon
  Therapeutic category:
S-SENSORY
  Formulation:
ORGANS N - OPHTHALMIC
  Available dmf:
US DMFCanada DMFEU DMFOther
 

  426-13-1
 Fluorometholone base
  Innovators:
Novartis
  Therapeutic category:
S-SENSORY ORGANS
  Formulation:
N - OPHTHALMIC
  Available dmf:
Japan DMFEU DMFOther
 

 51-21-8
 Fluorouracil
  Innovators:
Sanofi Aventis
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)G - PARENTERAL LONG-ACTING (Injectables)M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
US DMFJapan DMFCEPOther
 

  56296-78-7
 Fluoxetine hcl
  Innovators:
Eli Lilly
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)
  Available dmf:
US DMFCEPKorea DMFEU DMF
 

  397864-44-7
 Fluticasone furoate
  Innovators:
GlaxoSmithKline
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
Q - NASAL TOPICALR - LUNG ADMINISTRATION (Inhalation)
  Available dmf:
-
 

 80474-14-2
 Fluticasone propionate
  Innovators:
GlaxoSmithKline
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)Q - NASAL TOPICALR - LUNG ADMINISTRATION (Inhalation)
  Available dmf:
US DMFJapan DMFCEPEU DMF
 

  93957-55-2
 Fluvastatin sodium
  Innovators:
Novartis
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFEU DMFCanada DMFCEPOther
 

 61717-82-9
 Fluvoxamine maleate
  Innovators:
Solvay
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFJapan DMF
 

 183814-30-4
 Formoterol fumarate
  Innovators:
Novartis
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
R - LUNG ADMINISTRATION (Inhalation)
  Available dmf:
US DMFCEPCanada DMFJapan DMFKorea DMFOther
 

 129453-61-8
 FulvestrantAstra
  Innovators:
Zeneca
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)G - PARENTERAL LONG-ACTING (Injectables)
  Available dmf:
US DMFCEPCanada DMFOther
 

 54-31-9
 Furosemide
  Innovators:
Sanofi Aventis
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYF - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFJapan DMFCanada DMFCEP
 

 

_G_


  1953-04-4
 Galantamine hbr
  Innovators:
Sanochemia Pharmazeutika
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFCEPKorea DMFOther
 

 122111-03-9
 Gemcitabine hcl
  Innovators:
Eli Lilly
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
EU DMFUS DMFJapan DMFCEPKorea DMFCanada DMFOther
 

 

_H_


  52-86-8
 Haloperidol
  Innovators:
Johnson & Johnson
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
EU DMFUS DMFCanada DMFJapan DMFOther
 

 74050-97-8
 Haloperidol decanoate
  Innovators:
Johnson & Johnson
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
G - PARENTERAL LONG-ACTING (Injectables)
  Available dmf:
US DMFEU DMFCanada DMFOther
 

 58-93-5
 Hydrochlorothiazide
  Innovators:
Novartis
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFCanada DMFCEPKorea DMFJapan DMFOther
 

 

_I_


 936563-96-1
 Ibrutinib
  Innovators:
Johnson & Johnson
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

  138614-30-9
 Icatibant
  Innovators:
Shire
  Therapeutic category:
B-BLOOD AND BLOOD FORMING ORGANS
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMF
 

 57852-57-0
 Idarubicin hcl
  Innovators:
Pfizer
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
EU DMFUS DMFCanada DMFOther
 

 220127-57-1
 Imatinib mesylate
  Innovators:
Novartis
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFCanada DMFJapan DMFEU DMFKorea DMFOther
 

 113-52-0
 Imipramine hcl
  Innovators:
Sanofi Aventis
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY US DMFCEP
  Available dmf:
US DMFCEP
 

  99011-02-60
 Imiquimod
  Innovators:
3M
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
US DMFCanada DMFEU DMF
 

  138402-11-6
 Irbesartan
  Innovators:
Sanofi Aventis
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
Canada DMFCEPEU DMFUS DMFOther
 

 1201902-80-8
 Ixazomib
  Innovators:
CitrateTakeda
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 

_L_


 32780-64-6
 Labetalol hcl
  Innovators:
GlaxoSmithKline
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYF - PARENTERAL ORDINARY (Injectables)
  Available dmf:
CEPUS DMFJapan DMF
 

  84057-84-1
 Lamotrigine
  Innovators:
GlaxoSmithKline
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFEU DMF
 

 127984-74-1
 Lanreotide acetate
  Innovators:
Ipsen Group
  Therapeutic category:
H-SYSTEMIC HORMONAL PREPAR
  Formulation:
G - PARENTERAL LONG-ACTING (Injectables)
  Available dmf:
-
 

 103577-45-3
 Lansoprazole
  Innovators:
Takeda
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTINGF - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFJapan DMFCEPEU DMFOther
 

 130209-82-4
 Latanoprost
  Innovators:
Pfizer
  Therapeutic category:
S-SENSORY ORGANS
  Formulation:
N - OPHTHALMIC
  Available dmf:
US DMFEU DMFCanada DMF
 

 860005-21-6
 Latanoprostene bunod
  Innovators:
Valeant
  Therapeutic category:
S-SENSORY ORGANS
  Formulation:
N - OPHTHALMIC
  Available dmf:
-
 

 1256388-51-8
 Ledipasvir
  Innovators:
Gilead Sciences
  Therapeutic category:
J-GENERAL ANTI-INFECTIVES SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 112809-51-5
 Letrozole
  Innovators:
Novartis
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFEU DMFOther
 

 59-92-7
 Levodopa
  Innovators:
Roche
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING CEP
  Available dmf:
Canada DMFUS DMFBrazil DMFOther
 

 100986-85-4
 Levofloxacin
  Innovators:
Johnson & Johnson
  Therapeutic category:
J-GENERAL ANTI-INFECTIVES SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYF - PARENTERAL ORDINARY (Injectables)N - OPHTHALMIC
  Available dmf:
US DMFJapan DMFCanada DMFEU DMFOther
 

 50293-90-8
 Levosalbutamol hcl (levalbuterol)
  Innovators:
Sunovion Pharma
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
R - LUNG ADMINISTRATION (Inhalation)
  Available dmf:
US DMF
 

  851199-60-5
 Linaclotide
  Innovators:
Forest Labs
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMF
 

 668270-12-0
 Linagliptin
  Innovators:
Boehringer Ingelheim
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFKorea DMF
 

  165800-03-3
 Linezolid
  Innovators:
Pfizer
  Therapeutic category:
J-GENERAL ANTI-INFECTIVES SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
-
 

  34552-83-5
 Loperamide hcl
  Innovators:
McNeil
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)
  Available dmf:
US DMFCEPCanada DMFOther
 

 124750-99-8
 Losartan potassium
  Innovators:
Merck & Co.
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
Japan DMFEU DMFCEPCanada DMFUS DMFKorea DMFOther
 

  75330-75-5
 Lovastatin
  Innovators:
Merck & Co.
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFEU DMFCEPOther
 

  367514-88-3
 Lurasidone
  Innovators:
Sumitomo Dainippon Pharma
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMF
 

 

_M_


 61337-67-5
 Mirtazapine
  Innovators:
Schering-Plough
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFCEPEU DMFOther
 

 50-07-7
 Mitomycin
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFCEPCanada DMF
 

 102113?40?6
 Mometasone furoate
  Innovators:
Schering-Plough
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)Q - NASAL TOPICALR - LUNG ADMINISTRATION (Inhalation)
  Available dmf:
US DMFCEPEU DMFJapan DMF
 

 151567-02-1
 Montelukast sodium
  Innovators:
Merck & Co.
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTINGD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)
  Available dmf:
US DMFCEPEU DMFKorea DMFJapan DMFOther
 

 12650-69-0
 Mupirocin
  Innovators:
GlaxoSmithKline
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
CEPEU DMFUS DMFBrazil DMFOther
 

 115074-43-6
 Mupirocin calcium
  Innovators:
GlaxoSmithKline
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)Q - NASAL TOPICAL
  Available dmf:
US DMFCEPEU DMFCanada DMFOther
 

 115007-34-6
 Mycophenolate mofetil
  Innovators:
Roche
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)
  Available dmf:
US DMFJapan DMFCanada DMFCEPOther
 

 24280-93-1
 Mycophenolate sodium
  Innovators:
Novartis
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFOther
 

  441798-33-0
 Macitentan
  Innovators:
Actelion Pharma
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMF
 

  71-58-9
 Medroxyprogesterone acetate
  Innovators:
Pfizer
  Therapeutic category:
G-GENITO-URINARY SYSTEM & SEX HORMONAL
  Formulation:
A - ORAL SOLID ORDINARYG - PARENTERAL LONG-ACTING (Injectables)
  Available dmf:
US DMFCEPEU DMF
 

  595-33-5
 Megestrol acetate
  Innovators:
Par Pharma
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)
  Available dmf:
US DMFCEPEU DMF
 

 41100-52-1
 Memantine hcl
  Innovators:
Merz Pharma
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTINGD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)
  Available dmf:
EU DMFUS DMFCanada DMFOtherx
 

 41372-08-1
 Methyldopax
  Innovators:
C-CARDIOVASCULAR SYSTEM
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY CEPUS
  Available dmf:
DMFJapan DMFOther
 

  57432-61-8
 Methylergonovine maleate
  Innovators:
Novartis
  Therapeutic category:
G-GENITO-URINARY SYSTEM & SEX HORMONAL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFJapan DMFCEPOther
 

  2921-57-5
 Methylprednisolone hemisuccinate
  Innovators:
Pfizer
  Therapeutic category:
H-SYSTEMIC HORMONAL PREPAR
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFEU DMF
 

  2375-03-3
 Methylprednisolone sodium
  Innovators:
succinatePfizer
  Therapeutic category:
H-SYSTEMIC HORMONAL PREPAR
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
EU DMFJapan DMFOther
 

 98418-47-4
 Metoprolol succinate
  Innovators:
Astra Zeneca
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING US DMFCEPEU DMFOther
  Available dmf:
US DMFCEPEU DMFOther
 

 56392-17-7
 Metoprolol tartrate
  Innovators:
Novartis
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTINGF - PARENTERAL ORDINARY (Injectables)
  Available dmf:
CEPUS DMFCanada DMFOther
 

 208538-73-2
 Micafungin sodium
  Innovators:
Astellas
  Therapeutic category:
J-GENERAL ANTI-INFECTIVES SYSTEM
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
-
 

 

_N_


 22204-53-1
 Naproxen
  Innovators:
Hoffmann-La Roche
  Therapeutic category:
M-MUSCULO-SKELETAL SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTINGM - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
US DMFCEPCanada DMFOther
 

 26159-34-2
 Naproxen sodium
  Innovators:
Hoffmann-La Roche
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFCEPCanada DMF
 

 105816-04-4
 Nateglinide
  Innovators:
Ajinomoto
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFJapan DMFKorea DMF
 

  82752-99-6
 Nefazodone hcl
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFCanada DMF
 

 27848-84-6
 Nicergoline
  Innovators:
Pfizer
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
CEPJapan DMFOther
 

  21829-25-4
 Nifedipine
  Innovators:
Bayer
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFCEPCanada DMFJapan DMF
 

  923288-95-3
 Nilotinib hcl
  Innovators:
Novartis
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

  656247-17-5
 Nintedanib
  Innovators:
Boehringer Ingelheim
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 35189-28-7
 Norgestimate
  Innovators:
Johnson & Johnson
  Therapeutic category:
G-GENITO-URINARY SYSTEM & SEX HORMONAL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFEU DMFCanada DMF
 

 

_O_


 79517-01-4
 Octreotide acetate
  Innovators:
Novartis
  Therapeutic category:
H-SYSTEMIC HORMONAL PREPAR
  Formulation:
F - PARENTERAL ORDINARY (Injectables)G - PARENTERAL LONG-ACTING (Injectables)
  Available dmf:
US DMFEU DMFOther
 

 132539-06-1
 Olanzapine
  Innovators:
Eli Lilly
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYF - PARENTERAL ORDINARY (Injectables)
  Available dmf:
CEPUS DMFEU DMFCanada DMFKorea DMFOther
 

  144689-63-4
 Olmesartan medoxomil
  Innovators:
Daiichi
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFEU DMFBrazil DMFKorea DMFOther
 

  869477-96-3
 Olodaterol
  Innovators:
Boehringer Ingelheim
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
R - LUNG ADMINISTRATION (Inhalation)
  Available dmf:
-
 

  73590-58-6
 Omeprazole
  Innovators:
Astra Zeneca
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTINGD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFCEPJapan DMF
 

 99614-02-5
 Ondansetron base
  Innovators:
GlaxoSmithKline
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFEU DMF
 

 103639-04-9
 Ondansetron hcl
  Innovators:
GlaxoSmithKline
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFJapan DMFCEPKorea DMFEU DMFOther
 

 61825-94-3
 Oxaliplatin
  Innovators:
Sanofi Aventis
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFCEPEU DMFJapan DMF
 

 

_P_


 33069-62-4
 Paclitaxel
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFJapan DMFCEPCanada DMFKorea DMFOther
 

 571190-30-2
 Palbociclib
  Innovators:
Pfizer
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 144598-75-4
 Paliperidone
  Innovators:
Johnson & Johnson
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
B - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFEU DMF
 

 199739-10-1
 Paliperidone palmitate
  Innovators:
Johnson & Johnson
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
G - PARENTERAL LONG-ACTING (Injectables)
  Available dmf:
-
 

 135729-62-3
 Palonosetron hcl
  Innovators:
Roche
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFKorea DMFEU DMFOther
 

 40391-99-9
 Pamidronic acid
  Innovators:
Gador
  Therapeutic category:
M-MUSCULO-SKELETAL SYSTEM
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFEU DMFKorea DMFOther
 

 15500-66-0
 Pancuronium bromide
  Innovators:
3M
  Therapeutic category:
M-MUSCULO-SKELETAL SYSTEM
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFCEPCanada DMFOther
 

  199387-73-0
 Pantoprazole magnesium
  Innovators:
Takeda
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 138786-67-1
 Pantoprazole sodium
  Innovators:
Pfizer
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTINGD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFEU DMFCEPOther
 

 131918-61-1
 Paricalcitol
  Innovators:
Abbvie
  Therapeutic category:
H-SYSTEMIC HORMONAL PREPAR
  Formulation:
A - ORAL SOLID ORDINARYF - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFEU DMF
 

 78246-49-9
 Paroxetine hcl
  Innovators:
GlaxoSmithKline
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTINGD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)
  Available dmf:
US DMFJapan DMFEU DMFOther
 

 357166-30-4
 Pemetrexed disodium
  Innovators:
Eli Lilly
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFJapan DMFEU DMFOther
 

  942063-28-7
 Perampanel
  Innovators:
Eisai
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMF
 

  66104-23-2
 Pergolide mesylate
  Innovators:
Eli Lilly
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFJapan DMFCanada DMFCEP
 

 112529-15-4
 Pioglitazone HCl
  Innovators:
Takeda
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFJapan DMFCanada DMFEU DMFOther
 

 146464-95-1
 Pralatrexate
  Innovators:
Allos
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMF
 

 150322-43-3
 Prasugrel base
  Innovators:
Daiichi
  Therapeutic category:
B-BLOOD AND BLOOD FORMING ORGANS
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 1060616-79-6
 Prasugrel HBr
  Innovators:
Daiichi
  Therapeutic category:
B-BLOOD AND BLOOD FORMING ORGANS
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
EU DMFUS DMF
 

  389574-19-0
 Prasugrel HCl
  Innovators:
Daiichi
  Therapeutic category:
B-BLOOD AND BLOOD FORMING ORGANS
  Formulation:
EU DMFUS DMF
  Available dmf:
EU DMFUS DMF
 

  81131-70-6
 Pravastatin sodium
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFJapan DMFCEPKorea DMFEU DMFOther
 

 2920-86-7
 Prednisolone hemisuccinate
  Innovators:
H-SYSTEMIC HORMONAL PREPAR
  Therapeutic category:
F - PARENTERAL ORDINARY (Injectables)T - VAGINAL/INTRA-UTERINE (Women Health)
  Formulation:
Other
  Available dmf:
-
 

 148553-50-8
 Pregabalin
  Innovators:
Pfizer
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFEU DMFCanada DMFKorea DMFOther
 

  57-66-9
 Probenecid
  Innovators:
Merck & Co.
  Therapeutic category:
M-MUSCULO-SKELETAL SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFCEP
 

  99300-78-4
 Venlafaxine hcl
  Innovators:
Pfizer
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFCEPEU DMFOther
 

  165800-06-6
 Zoledronic acid
  Innovators:
Novartis
  Therapeutic category:
M-MUSCULO-SKELETAL SYSTEM
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFJapan DMFEU DMFCanada DMFOther
 

 

_Q_


 111974-72-2
 Quetiapine fumarate
  Innovators:
Astra Zeneca
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFEU DMFCanada DMFKorea DMFOther
 

 

_R_


 128517-07-7
 Romidepsin
  Innovators:
Astellas
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMF
 

 147098-20-2
 Rosuvastatin calcium
  Innovators:
Astra Zeneca
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
CEPUS DMFJapan DMFEU DMFOther
 

  99755-59-6
 Rotigotine
  Innovators:
UCB Pharma
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
J - OTHER SYSTEMIC
  Available dmf:
-
 

 115436-72-1
 Risedronate sodium
  Innovators:
Procter & Gamble
  Therapeutic category:
M-MUSCULO-SKELETAL SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
EU DMFCanada DMFUS DMFKorea DMF
 

 106266-06-2
 Risperidone
  Innovators:
Cilag
  Therapeutic category:
N-CENTRAL NERVOUS SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)G - PARENTERAL LONG-ACTING (Injectables)
  Available dmf:
US DMFJapan DMFCEPKorea DMFEU DMFOther
 

 366789-02-8
 Rivaroxaban
  Innovators:
Bayer
  Therapeutic category:
B-BLOOD AND BLOOD FORMING ORGANS
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
Korea DMF
 

 

_S_


 18559-94-9
 Salbutamol (albuterol)
  Innovators:
GlaxoSmithKline
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
R - LUNG ADMINISTRATION (Inhalation)
  Available dmf:
Canada DMFOther
 

 51022-70-9
 Salbutamol (albuterol) sulfate
  Innovators:
GlaxoSmithKline
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)F - PARENTERAL ORDINARY (Injectables)R - LUNG ADMINISTRATION (Inhalation)
  Available dmf:
EU DMFUS DMFCanada DMFJapan DMFOther
 

 361442-04-8
 Saxagliptin
  Innovators:
Bristol Meyers Squibb
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
Korea DMF
 

 475086-01-2
 Selexipag
  Innovators:
Actelion Pharmaceuticals
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

  171599-83-0
 Sildenafil citrate
  Innovators:
Pfizer
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)
  Available dmf:
CEPUS DMFEU DMFCanada DMFOther
 

 22199-08-2
 Silver sulfadiazine
  Innovators:
King Pharma
  Therapeutic category:
D-DERMATOLOGICALS
  Formulation:
D - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
US DMFEU DMFOther
 

 65666-07-1
 Silymarin
  Innovators:
Madaus
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARYD - ORAL LIQUID ORDINARY (Drops/ Syrups/ Solubles…)F - PARENTERAL ORDINARY (Injectables)M - TOPICAL/ DERMATOLOGICAL (Ointements/ Creams/ Lotions/ Gels…)
  Available dmf:
CEPEU DMFKorea DMFOther
 

  79902-63-9
 Simvastatin
  Innovators:
Merck & Co.
  Therapeutic category:
C-CARDIOVASCULAR SYSTEM
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
CEPJapan DMFUS DMFKorea DMFEU DMF
 

 1240039-02-4
 Sitagliptin malate
  Innovators:
Merck & Co.
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
EU DMF
 

 654671-77-9
 Sitagliptin phosphate
  Innovators:
Merck & Co.
  Therapeutic category:
A-ALIMENTARY TRACT & METABOL
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMF
 

  1190307-88-0
 Sofosbuvir
  Innovators:
Gilead Sciences
  Therapeutic category:
J-GENERAL ANTI-INFECTIVES SYSTEM
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
-
 

 242478-38-2
 Solifenacin succinate
  Innovators:
Astellas
  Therapeutic category:
G-GENITO-URINARY SYSTEM & SEX HORMONAL
  Formulation:
A - ORAL SOLID ORDINARYB - ORAL SOLID LONG-ACTING
  Available dmf:
US DMFEU DMFCanada DMFKorea DMF
 

 475207-59-1
 Sorafenib tosylate
  Innovators:
Bayer
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
EU DMF
 

 557795-19-4
 Sunitinib base
  Innovators:
Pfizer
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
EU DMF
 

  341031-54-7
 Sunitinib malate
  Innovators:
Pfizer
  Therapeutic category:
L-ANTINEOPLASTIC & IMMUNOMODUL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
EU DMFUS DMF
 

 

_T_


 37686-85-4
 Terguride
  Innovators:
Spofa United Pharmaceutical Works
  Therapeutic category:
G-GENITO-URINARY SYSTEM & SEX HORMONAL
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFEU DMFJapan DMF
 

  274693-27-5
 Ticagrelor
  Innovators:
Astra Zeneca
  Therapeutic category:
B-BLOOD AND BLOOD FORMING ORGANS
  Formulation:
A - ORAL SOLID ORDINARY
  Available dmf:
US DMFKorea DMF
 

  220620-09-7
 Tigecycline
  Innovators:
Pfizer
  Therapeutic category:
J-GENERAL ANTI-INFECTIVES SYSTEM
  Formulation:
F - PARENTERAL ORDINARY (Injectables)
  Available dmf:
US DMFEU DMFCanada DMFOther
 

 26921-17-5
 Timolol maleate
  Innovators:
Merck & Co.
  Therapeutic category:
S-SENSORY ORGANS
  Formulation:
N - OPHTHALMIC
  Available dmf:
CEPUS DMFCanada DMFJapan DMFKorea DMF
 

 136310-93-5
 Tiotropium bromide
  Innovators:
Boehringer Ingelheim
  Therapeutic category:
R-RESPIRATORY SYSTEM
  Formulation:
R - LUNG ADMINISTRATION (Inhalation)
  Available dmf: